Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33033

1.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
2.

The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus.

Pergolizzi JV Jr, Mercadante S, Echaburu AV, Van den Eynden B, Fragoso RM, Mordarski S, Lybaert W, Beniak J, Orońska A, Slama O; Euromed Communications meeting.

Curr Med Res Opin. 2009 Jun;25(6):1517-28. doi: 10.1185/03007990902920731.

PMID:
19435402
3.

The use of long-acting opioids in chronic pain management.

Vallerand AH.

Nurs Clin North Am. 2003 Sep;38(3):435-45. Review.

PMID:
14567201
4.

Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.

Trescot AM, Helm S, Hansen H, Benyamin R, Glaser SE, Adlaka R, Patel S, Manchikanti L.

Pain Physician. 2008 Mar;11(2 Suppl):S5-S62. Review.

6.

Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.

Kress HG.

Eur J Pain. 2009 Mar;13(3):219-30. doi: 10.1016/j.ejpain.2008.04.011. Epub 2008 Jun 24. Review.

PMID:
18567516
7.

Transdermal buprenorphine in cancer pain and palliative care.

Sittl R.

Palliat Med. 2006;20 Suppl 1:s25-30. Review.

PMID:
16764218
8.

Opioid switch in palliative care, opioid choice by clinical need and opioid availability.

Müller-Busch HC, Lindena G, Tietze K, Woskanjan S.

Eur J Pain. 2005 Oct;9(5):571-9. Epub 2005 Jan 20.

PMID:
16139186
9.

Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.

Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, Villari P, Ficorella C, Gebbia V, Riina S, Casuccio A, Mangione S.

Eur J Pain. 2008 Nov;12(8):1040-6. doi: 10.1016/j.ejpain.2008.01.013. Epub 2008 Mar 18.

PMID:
18353696
10.

[Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine].

Binhas M, Krakowski I, Marty J.

Ann Fr Anesth Reanim. 2007 Jun;26(6):502-15. Epub 2007 Jun 8. Review. French.

PMID:
17560755
11.
13.

Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.

Wirz S, Wittmann M, Schenk M, Schroeck A, Schaefer N, Mueller M, Standop J, Kloecker N, Nadstawek J.

Eur J Pain. 2009 Aug;13(7):737-43. doi: 10.1016/j.ejpain.2008.09.005. Epub 2008 Oct 31.

PMID:
18977159
17.

Transdermal buprenorphine in the treatment of chronic pain.

Sittl R.

Expert Rev Neurother. 2005 May;5(3):315-23. Review.

PMID:
15938664
18.

Opioids for cancer pain - an overview of Cochrane reviews.

Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA.

Cochrane Database Syst Rev. 2017 Jul 6;7:CD012592. doi: 10.1002/14651858.CD012592.pub2. Review.

PMID:
28683172
19.

Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.

Griessinger N, Sittl R, Likar R.

Curr Med Res Opin. 2005 Aug;21(8):1147-56.

PMID:
16083522

Supplemental Content

Support Center